Optima Health PLC Director/PDMR Shareholding
19 December 2024 - 6:00PM
RNS Regulatory News
RNS Number : 6516Q
Optima Health PLC
19 December 2024
19 December 2024
Optima Health plc
("Optima Health" or
the "Company")
Director / PDMR
Shareholding
Optima Health plc (AIM: OPT), the UK's leading
provider of technology enabled corporate health and wellbeing
solutions, announces that it was notified on 18 December 2024, that
Jonathan Thomas, (Chief Executive Officer of the Company) purchased
13,559 ordinary shares of £0.01 in the Company ("Ordinary Shares")
at a price of 147.4 pence per share.
Following this, Jonathan Thomas holds an
interest of 217,106 Ordinary Shares, representing approximately
0.24% of the current issued share capital.
Contacts:
|
Optima
Health
|
|
|
Jonathan Thomas, CEO
Heidi Giles, CFO
|
+44(0)3300085113
media@OptimaHealth.co.uk
|
|
|
|
|
Nominated Adviser and Corporate Broker
|
|
|
Panmure Liberum Limited
|
+44 (0)20 3100 2000
|
|
Emma Earl / Will Goode/ Mark Rogers / Rupert
Dearden
|
|
|
|
|
|
UK Financial PR Adviser
ICR Consilium
Mary-Jane Elliott / Angela Gray /
Chris Welsh
|
optimahealth@icrinc.com
|
About Optima Health
Optima Health is the UK's leading
provider of occupational health and wellbeing services, directly
influencing and improving people's lives for 25 years. Optima
Health's incredible team of professionals quickly and effectively
encapsulate client's needs, supporting organisations of all shapes
and sizes. Through tailored solutions and innovative systems,
Optima Health offers unparalleled clinical expertise to its
clients. These solutions ensure that processes are simple and allow
its clients to spend more time focusing on their employees driving
a healthy, high-performing workplace. For more information visit
www.optima health.co.uk
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Jonathan Thomas
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Executive Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Optima Health plc
|
|
b)
|
LEI
|
213800TOPWJSRCW4ON08
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
|
Ordinary Shares of £0.01
each
|
|
|
|
|
Identification code
|
GB00BRSCY602
|
|
|
|
|
b)
|
Nature of the transaction
|
Purchase of shares
|
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Purchase Price
|
Volume
|
|
|
|
|
147.4 pence
|
13,559
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
|
|
- Aggregated volume
|
13,559 shares
|
|
|
147.4 pence
|
|
- Price
|
|
|
|
|
|
e)
|
Date of the transaction
|
18 December 2024
|
|
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market
(XLON)
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHFFLFWAELSEFE
Optima Health (LSE:OPT)
Historical Stock Chart
From Nov 2024 to Dec 2024
Optima Health (LSE:OPT)
Historical Stock Chart
From Dec 2023 to Dec 2024
